New Trials and Future Directions in Endometrial Cancer and Vaginal Cuff Brachytherapy

This session presents attendees with information regarding practical treatment approaches to endometrial cancer including a discussion on guidelines, new trials, future directions, program building, and difficult cases. Attendees hear about clinical approaches to vaginal cuff brachytherapy and have the opportunity to ask questions and interact with panelists to better understand how to approach such cases in their own clinical practice. 

The content was originally presented and recorded as a live webinar series on September 4 and September 11, 2024.

Target Audience

This activity is designed to meet the interests of radiation oncologists, medical oncologists, radiation oncology residents. 

Learning Objectives

Upon completion of this activity, participants should be able to do the following: 

  • Incorporate adjuvant radiation therapy into current practice in the context of new clinical data.
  • Better understand the molecular factors influencing how we care for endometrial cancer patients.
  • Identify challenges faced in light of new immunotherapy clinical trials. 
  • Implement approaches to endometrial cancer treatment with radiation including external beam and vaginal brachytherapy.  
Course summary
Available credit: 
  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.
Course opens: 
07/25/2024
Course expires: 
10/09/2026
Cost:
$0.00
Part of: 
How to Optimally Deliver Vaginal Cuff Brachytherapy for Endometrial Cancer in Your Practice: Tips and Tricks From the Experts
Rating: 
0
  • Lara Hathout, MD, FRCPC, is employed by Rutgers Cancer Institute of New Jersey. Dr. Hathout receives compensation as a consultant from the RTOG Foundation. 
  • Matthew Harkenrider, MD, is employed by Loyola University Medical Center. Dr. Harkenrider receives compensation as a consultant from the RTOG Foundation and from NEED. 
  • Idalid Ivy Franco, MD, MPH, is employed by Brigham and Women's Hospital/Dana-Farber Cancer Institute. Dr. Franco receives grant/research funding from the National Cancer Institute, NIH/NCI, Brigham and Women's Hospital/Dana-Farber Cancer Institute and ASTRO/RTOG NRG Oncology Health Equity Fellowship. Dr. Franco is Executive Vice Chair of the Equity and Inclusion Subcommittee for ARRO and serves as Vice Chair of the Health Equity Education Committee for the Council on Health Equity Diversity and Inclusion with ASTRO.
Disclosure link: 
Committee Disclosure

The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council of Continuing Medical Education to provide continuing education to physicians.

ASTRO is awarded Deemed Status by the American Board of Radiology to provide SA-CME as part of Part II Maintenance of Certification.

Available Credit

  • 1.50 AMA PRA Category 1 Credit™
    The American Society for Radiation Oncology (ASTRO) is accredited by the Accreditation Council for Continuing Medical Education for physicians. ASTRO designates this for a maximum of 1.50 AMA PRA Category 1 Credit™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
  • 1.50 Certificate of Attendance
    This activity was designated for 1.50 AMA PRA Category 1 Credit™.

Price

Cost:
$0.00
Please login or register to take this course.